Hikma shares rally after US launch of Advair generic resumes

Shares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US, after clearing up a final piece of bureaucracy with the FDA.

Chasing Mylan, Hikma tries again with rejected generic Advai...

Shingrix and Trelegy shield GSK from Advair fallout

Shingles vaccine boosts GSK as generic Advair bites

GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of declining Advair sales.

Advair reprieve gives GSK breathing space

GlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the FDA raised problems with a challenger.

GSK's new pharma chief Miels to join in September

Luke Miels to start role after GSK and AZ end contract row.